Pro Health Tips
Saturday, 27 February 2021
FDA Withdraws Durvalumab Indication For Bladder Cancer
Immunotherapy drug- Durvalumab's indication for the treatment of bladder cancer has been withdrawn in the US after it failed to improve survival.
from Medindia Health News https://ift.tt/2ZW91Q5
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Immunotherapy drug- Durvalumab's indication for the treatment of bladder cancer has been withdrawn in the US after it failed to improve survival.
No comments:
Post a Comment